Documentos de Académico
Documentos de Profesional
Documentos de Cultura
1. Introduction
Tissue engineering presents an alternative approach to repair or replace lost or damaged
human tissue resulting from injury or disease.[1] The discipline encompasses an understanding of the attachment and proliferation of progenitor cells [2,3] or growth factors
[4] onto scaffolds. Skeletal tissue is a highly organized structure comprising of mainly
type I collagen, nanometre-sized carbonate-substituted hydroxyapatite (HAp) crystals,
water, and various other noncollagenous proteins. Collagen type I presents natural binding sites such as Arg-Gly-Asp (RGD) and Asp-Gly-Glu-Ala (DGEA) peptide sequences
2032
that modulate the adhesion of osteoblasts and broblasts.[5,6] A major limitation for
the use of collagen alone is its low mechanical strength, high swelling capacity, and
rapid degradation. HAp is a common excipient used to reinforce collagen in matrices
intended for tissue engineering.[710] HAp is a mineral (a form of calcium apatite),
and, therefore, lacks the natural binding sites presented in collagen. It also has certain
drawbacks such as limited biodegradability and osteointegration properties.[11]
Several additional excipients have, therefore, been explored to limit the use of high
ratios of HAp in collagen/HAp matrices. Examples include gelatin,[12] poly(-lactideco-verepsilon-caprolactone),[3] Poly L-lactic acid,[13] and Poly-benzyl-L-glutamate.[14]
This research proposes to strengthen a collagen/HAp matrix that is reinforced via crosslinking with glutaraldehyde as the cross-linking agent. Strengthening via cross-linking is
expected to enhance mechanical strength, decrease swelling and degradation rate at relatively low concentrations of HAp. Glutaraldehyde has previously been used to strengthen
collagen scaffolds.[15] The microstructural mechanism for reinforced strength has been
reported to be due to increased resistance to bril rotation.[16]
2.
2.1.
The use of rat tail tendon for tissue engineering applications is well established in literature.[17] In this study, type I collagen was extracted from Sprague Dawley rat tail tendons in a manner similar to that described by Liu et al. [18] with modications.
Sprague Dawley rat tails were obtained from the animal house of Indian Institute of
Chemical Biology, India. HAp was prepared by microwave synthesis using the method
used by Liu et al. [19]
2.2.
The purity of isolated collagen was analyzed using sodium dodecyl sulfate poly acrylamide gel electrophoresis (SDS-PAGE) according to the method described by lammelli.[20]
Briey, a 3% stacking gel was prepared from a stock solution of 30% w/w acrylamide and
0.8% w/w of N,N bis methylene acrylamide. The nal concentration of gel prepared for
separation was 0.375 M TrisHCl (pH 8.8) and 0.1% SDS. Tetramethylenediamine and
ammonium persulfate were used for gel polymerization, and the casted gel was cut to a
dimension of 15 cm 6 cm. The sample was immersed in boiling water for 1.5 min to
enable protein dissociation. The electrophoresis was performed with a current of 3 mA per
gel until the bromophenol blue marker reached the bottom of the gel (about 78 h). The
proteins were xed in the gel with 50% TCA overnight, stained for 1 h at 37 C with a
0.1% coomassie brilliant blue solution made freshly in 50% TCA. The gels were then
washed repeatedly in 7% acetic acid prior to taking the autoradiograph.
2.3.
Fabrication of scaffolds
A 0.5% w/v solution of collagen in acetic acid was used as the stock solution for scaffold
preparation. HAp was added to correspond to a collagen:HAp ratio of 1:2, 1:4, or 1:6.
The solution mixtures were gradually frozen and subsequently lyophilized to obtain
scaffolds. The HAp-containing scaffolds were cross-linked by immersion in a
glutaraldehyde bath of concentration 0.3% and pH 8.0 for 2 h at room temperature. The
scaffolds were then washed repeatedly with distilled water, and then lyophilized for an
additional 14 h at 40 C to eliminate water without loss of structural integrity (Table 1).
Specimen
Collagen:
hydroxyapatite (w/w)
Concentration of collagen
solution (w/v) in acetic acid, %
Collagen
CH1
CH2
CH3
1:2
1:4
1:6
0.5
0.5
0.5
0.5
2.4.
2033
Characterization of scaffolds
Esw
We W0
100
W0
(3) Water permeation: Water permeation studies were performed following protocol
described by Sato et al. (2010).[22] Briey, a water reservoir was attached with
a polyethylene tube. The collagen and its composite scaffold of about 4 cm in
length were connected to the other end of polyethylene tube. The water reservoir
was set to a height of about 165 cm. A pressure transducer was set to verify a
120 mm Hg pressure constantly at its distal end. The permeated water through
2034
the scaffold structure was collected with respect to time(s) in a graduated cylinder in order to calculate in mL/min/cm2.
(4) Biodegradability: In vitro degradation tests of cross-linked collagen-HAp
scaffolds were performed using bacterial collagenase obtained from Clostridium
histolyticum (EC 3.4.24.3, Sigma Chemical Co., St. Louis, MO, USA) with a
collagenase activity of 300 units/mg. The in vitro degradation studies for
collagen and its composite scaffolds were performed at 37 C in 10 mL phosphate buffered solution (pH 7.4) containing collagenase in CO2 incubator
(Lishen HF151UV). The dynamic degradation of scaffolds was monitored for
four compositions with known dry weights by incubated at varying collagenase
concentrations (0.1, 0.5, 1, and 2 mg) for 24 h.
2.5.
2035
The prepared scaffolds were cut into cylindrical disks with a 6 mm dermal biopsy
punch (Miltex) and kept in a 96-well plate. They were sterilized with 70% ethyl alcohol
(v/v) followed by UV treatment, followed by hydration in sterile PBS (pH 7.4). The
scaffolds were then conditioned in DMEM medium for 4 h before cell seeding. Cells
were seeded at densities of 1 105 cells/well on these scaffolds. The seeded constructs
were incubated for 3 or 5 days at 37 C and 5% CO2 to examine for growth and proliferation. The numbers of living cells inside the scaffold were determined using the MTT
assay. After discarding the culture media, the cells were further washed with PBS to
remove the non-adhered cells. One ml/well of fresh medium and 100 l/well of MTT
was added to the wells, and the cells were cultured for an additional 4 h. The same procedure was repeated for 3 identical samples, except that these were cultured for an additional 12 h. The medium was then removed, and 150 l of dimethyl sulfoxide (DMSO)
was added to each well. The optical density (OD) was measured at wavelength 595 nm
using a microplate reader (Model PerkinElmer 2030 explorer). The percentages of
attached cells were calculated using following formula as:
The OD595 of cells on matrix after washing
100%
The OD595 of cells in culture wells
Results
2036
Figure 1. Scanning electron micrographs of: (a) collagen scaffold; (b) collagen:HAp (1:2), (c)
collagen:HAp (1:4); and (d) collagen:HAp (1:6).
Figure 2.
Figure 3.
2037
2038
Figure 4.
3.1.4.
Infrared analysis
These studies were performed to ensure that the cross-linking with HAp does not affect
the chemistry of collagen. This is important considering that cells are more prone to
attach surfaces containing natural binding sites.[26]
Infrared spectrum of a composite scaffold is shown in Figure 4. The FTIR spectra
showed peaks at 3485.6 cm1 and 1529.57 cm1. These were in the range of -NH
stretching and N-H bending of secondary amide on collagen type I, indicating that these
functional groups may still be available to promote cell attachment to collagen. HAp is
characterized by an anti-symmetric phosphate band at around 12001000 cm1.[27] The
peak observed at 1203.5 cm1 in Figure 4 corresponds to phosphate stretching, and
conrms the presence of HAp in the scaffold.
3.1.5. Biodegradability testing
Figure 5 shows that the cross-linked collagen-HAp scaffolds showed greater
resistance to degradation than the pure collagen scaffolds in all collagenase
solutions.
3.1.6. Hemo-compatibility testing
Blood compatibility is a critical requirement for the blood interfacing biomaterials. The
implants should not damage proteins, enzymes, or elements of blood (red blood cells,
white blood cells, and platelets). Figure 6 shows that the % hemolysis increased two to
three times for the cross-linked collagen/HAp scaffolds compared to pure collagen
scaffolds.
Figure 5.
2039
3.1.7. Attachment and proliferation of mesenchymal stem cells onto the scaffolds
The results for MTT and cell adhesion assay are shown in Figure 7. The results were
plotted by measuring the OD and reported as percentage of cells adhered relative to
seeded MSCs. The attachment ratios were found to be more than 50% in all cases when
2040
Figure 7.
Figure 8. (a) and (b) Two representative uorescent microscopy photographs of calcein AM
staining in collagen/HAp scaffolds of ratio 1:2. (c) The scaffold after 72 h of incubation.
MSCs were cultivated for 12 h in the media and seeded over the scaffold. Cell proliferations were performed for 3 and 5 days, and signicant increases were observed.
2041
Figure 9. Tissue reaction to cross-linked scaffolds of ratio 1:2 at 3 days (a), 7 days (b), 14 days
(c), and at 28 days (d) after subcutaneous implantation in Sprague Dawley rats. The representative
scaffold shown here represents a ratio of collagen/HAp of 1:2.
The tissue reaction was assessed by histopathology (Figure 9). Tissue response at days
3 and 7 was that of an acute inammatory reaction mediated by neutrophilic inltration.
The reaction then shifted to chronic inammation predominated by macrophages by
14 days. The chronic inammation persisted at 28 days, but the reaction was less intense
compared to response at day 14. There was evidence of healing by brosis from day
seven, progressing until the 28th day.
4.
Discussion
2042
possess signicantly greater surface area compared to pure collagen scaffolds. The pore
sizes obtained in our study were similar to that of Chen et al. [28] Such dissimilar morphologies consisting of a highly porous structure and high mechanical strength may
have potential for the design of dermal implants. The porous surface can facilitate the
recruitment and proliferation of dermal broblasts to promote wound healing, while
composite structure can contribute to mechanical strength and barrier efcacy to prevent
infection and dehydration.[29] The roughly spherical shape of the pores as well as their
presence on the surface suggests that pore diameters may be inuenced by the size of
the evaporating solvent droplets as well as particle size of HAp.[30] Pores over the surface of the scaffold are most common sites of stress concentrator and crack initiator.
But incorporation of HAp increases the density of the composite material which retards
crack propagation. Moreover, the decrease in pore size for the composite improves the
circularity index of the pores and hence decreases crack propagation.[31] This property
has been veried with measurement of ultimate strength (Figure 2) where increase in
addition of HAp improves compressive strength of the scaffold. These observations are
consistent with previous literature.[32] The possible reason may be explained by either
an increase in total binding area of collagen with HAp or reduction of defects in case
of composite scaffold, both of which may lead to an increase in mechanical strength.
This conclusion is further supported by our decrease in swelling ratio for composite
scaffold. Okoshi et al. proposed that porous grafts with water permeability of about 10
40 mL/min/cm2 induced endothelization and kept patency.[33] The porosity of both collagen and composite scaffolds was in a comparable range.
A decrease in availability of interactive surface area in the composite scaffold
results lowers swelling, water permeation, and therefore exposure to enzymes responsible for degradation. The collagen/HAp scaffolds may therefore be expected to have a
lower degradation rate and a greater residence time following implantation.
While the mechanical and degradation properties of the collagen/HAp scaffolds
seem favorable, a drawback of the glutaraldehyde cross-linking is the lower hemocompatibility compared to pure collagen scaffolds. As both collagen and HAp were considered biocompatible, the decrease may be a consequence of residual glutaraldehyde
entrapped in the collagen-HAp composites. It is possible that the amount of residual
glutaraldehyde is higher in scaffolds containing greater amount of HAp. This outcome
is further supported by the fact that the collagen:HAp (1:2) composite showed nearly
same proliferation rate as that of pure collagen, while the composite with higher ratio
showed decreased cell proliferation and attachment.
5.
Conclusion
This study shows that cross-linked collagen-HAp scaffolds may present a valuable bone
tissue engineering platform. Advantages include a relatively slow degradation rate, high
mechanical strength, and a collagenous macroporous structure with potential to trigger
cell attachment and proliferation. The biocompatibility of composite scaffold though
found to be less than those of pure collagen scaffold, the collagen:HAp with 1:2 composite has comparable degree of cell adhesion and viability with those of pure collagen.
However, there is decrease in haemocompatibility with the increasing concentration of
HAp which may be due to increased amount of glutaraldehyde retention in the
composite.
2043
Acknowledgment
The Indian Institute of Chemical Biology, Kolkata for providing the facilities for conducting the
various tests, especially Dr T Chakraborty.
References
[1] Hutmacher DW. Scaffold design and fabrication technologies for engineering tissuesstate of
the art and future perspectives. J. Biomater. Sci., Polym. Ed. 2001;12:107124.
[2] Moshaverinia A, Ansari S, Chen C, Xu X, Akiyama K, Snead ML, Zadeh HH, Shi S. Coencapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate
microspheres for bone tissue engineering. Biomaterials. 2013;34:65726579.
[3] Akkouch A, Zhang Z, Rouabhia M. Engineering bone tissue using human dental pulp stem
cells and an osteogenic collagen-hydroxyapatite-poly(-lactide-co-{varepsilon}-caprolactone)
scaffold. J. Biomater. Appl. 2013. doi: 10.1177/0885328213486705.
[4] Yun YR, Lee S, Jeon E, Kang W, Kim KH, Kim HW, Jang JH. Fibroblast growth factor 2functionalized collagen matrices for skeletal muscle tissue engineering. Biotechnol. Lett.
2012;34:771778.
[5] Dedhar S, Ruoslahti E, Pierschbacher MD. A cell surface receptor complex for collagen type
I recognizes the Arg-Gly-Asp sequence. J. Cell Biol. 1987;104:585593.
[6] Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA, Santoro SA. Identication of a
tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J. Biol. Chem.
1991;266:73637367.
[7] Li J, Chen Y, Mak AF, Tuan RS, Li L, Li Y. A one-step method to fabricate PLLA scaffolds
with deposition of bioactive hydroxyapatite and collagen using ice-based microporogens.
Acta Biomater. 2010;6:20132019.
[8] Perez RA, Altankov G, Jorge-Herrero E, Ginebra MP. Micro- and nanostructured hydroxyapatite-collagen microcarriers for bone tissue-engineering applications. J. Tissue Eng. Regen.
Med. 2013;7:353361.
[9] Ning L, Malmstrom H, Ren YF. Porous collagen-hydroxyapatite scaffolds with mesenchymal
stem cells for bone regeneration. J. Oral. Implantol. 2013. doi: 10.1563/AAID-JOI-D-1200298.
[10] Sionkowska A, Kozlowska J. Properties and modication of porous 3-D collagen/hydroxyapatite composites. Int. J. Biol. Macromol. 2013;52:250259.
[11] Rupani A, Hidalgo-Bastidan LA, Rutten F, Dent A, Turner I, Cartmell S. Osteoblast activity
on carbonated hydroxyapatite. J. Biomed. Mater. Res. A. 2012;100:10891096.
[12] Vozzi G, Corallo C, Carta S, Fortina M, Gattazzo F, Galletti M, Giordano N. Collagen-gelatingenipin-hydroxyapatite composite scaffolds colonized by human primary osteoblasts are suitable for bone tissue engineering applications: in vitro evidences. J. Biomed. Mater. Res. A.
2013. doi: 10.1002/jbm.a.3482310.1002/jbm.a.34823.
[13] Chen Y, Mak A, Wang M, Li J, Wong M. PLLA scaffolds with biomimetic apatite coating
and biomimetic apatite/collagen composite coating to enhance osteoblast-like cells attachment and activity. Surf. Coat. Technol. 2006;201:575580.
[14] Ravichandran R, Venugopal JR, Sundarrajan S, Mukherjee S, Ramakrishna S. Precipitation
of nanohydroxyapatite on PLLA/PBLG/collagen nanobrous structures for the differentiation
of adipose derived stem cells to osteogenic lineage. Biomaterials. 2012;33:846855.
[15] Lickorish D, Ramshaw JA, Werkmeister JA, Glattauer V, Howlett CR. Collagen-hydroxyapatite composite prepared by biomimetic process. J. Biomed. Mater. Res. A. 2004;68:1927.
[16] Chandran PL, Paik DC, Holmes JW. Structural mechanism for alteration of collagen gel
mechanics by glutaraldehyde crosslinking. Connect Tissue Res. 2012;53:285297.
[17] Rajan N, Habermehl J, Cote MF, Doillon CJ, Mantovani D. Preparation of ready-to-use,
storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications. Nat. Protoc. 2006;1:27532758.
[18] Liu XD, Skold M, Umino T, Zhu YK, Romberger DJ, Spurzem JR, Rennard SI. Endothelial
cell-mediated type I collagen gel contraction is regulated by hemin. J. Lab. Clin. Med.
2000;136:100109.
[19] Liu X, Li K, Wang H, Zhu M, Yan H. Rapid formation of hydroxyapatite nanostructures by
microwave irradiation. Chem. Phys. Lett. 2004;396:429432.
2044
[20] Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680685.
[21] Shanmugasundaram N, Ravichandran P, Reddy PN, Ramamurty N, Pal S, Rao KP.
Collagen-chitosan polymeric scaffolds for the in vitro culture of human epidermoid carcinoma cells. Biomaterials. 2001;22:19431951.
[22] Sato M, Nakazawa Y, Takahashi R, Tanaka K, Sata M, Aytemiz D, Asakura T. Small-diameter vascular grafts of Bombyx mori silk broin prepared by a combination of electrospinning
and sponge coating. Mater. Lett. 2010;64:17861788.
[23] Qu X-H, Wu Q, Chen G-Q. In vitro study on hemocompatibility and cytocompatibility
of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). J. Biomater. Sci., Polym. Ed.
2006;17:11071121.
[24] Hutmacher DW, Goh JC, Teoh SH. An introduction to biodegradable materials for tissue
engineering applications. Ann. Acad. Med. Singapore. 2001;30:183191.
[25] Netaji E, Mirzadeh H, Zandi M. Synthesis and characterization of nano-hydroxyapatite rods/
poly(l-lactide acid) composite scaffolds for bone tissue engineering. Composites Part A.
2008;39:15891596.
[26] Venugopal J, Low S, Choon AT, Kumar AB, Ramakrishna S. Electrospun-modied nanobrous scaffolds for the mineralization of osteoblast cells. J. Biomed. Mater. Res. A.
2008;85:408417.
[27] Rehman I, Boneld W. Characterization of hydroxyapatite and carbonated apatite by photo
acoustic FTIR spectroscopy. J. Mater. Sci.-Mater. Med. 1997;8:14.
[28] Chen CH, Kuo SM, Liu GS, Chen WN, Chuang CW, Liu LF. Enhancement of neurite outgrowth in neuron cancer stem cells by growth on 3-D collagen scaffolds. Biochem. Biophys.
Res. Commun. 2012;428:6873.
[29] Boyan BD, Hummert TW, Dean DD, Schwartz Z. Role of material surfaces in regulating
bone and cartilage cell response. Biomaterials. 1996;17:137146.
[30] Swaminathan V, Tchao R, Jonnalagadda S. Physical characterization of thin semi-porous
poly(L-lactic acid)/poly(ethylene glycol) membranes for tissue engineering. J. Biomater. Sci.,
Polym. Ed. 2007;18:13211333.
[31] Hattiangadi A, Bandyopadhyay A. strength degradation of nonrandom porous ceramic structures under uniaxial compressive loading. J. Am. Ceram. Soc. 2004;83:27302736.
[32] Danninger H, GQueeney R. Strength degradation of nonrandom porous ceramic structures
under uniaxial compressive loading. J. Am. Ceram. Soc. 2000;83:27302736.
[33] Okoshi T, Soldani G, Goddard M, Galletti PM. Penetrating micropores increase patency and
achieve extensive endothelialization in small diameter polymer skin coated vascular grafts.
ASAIO J. 1996;42:M398401.